Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Apollo TMS Therapy System

K-Number: K180313 · 2018-05-04

Decision Date2018-05-04
Product CodeOBP
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Apollo TMS Therapy System is a medical device manufactured by Mag & More GmbH. It received FDA 510(k) clearance on 2018-05-04 under approval number K180313. The device is classified under product code OBP. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Apollo TMS Therapy System?

Apollo TMS Therapy System is a medical device that received FDA 510(k) clearance on 2018-05-04. It is manufactured by Mag & More GmbH. The 510(k) number is K180313.

When was Apollo TMS Therapy System approved by the FDA?

Apollo TMS Therapy System received FDA 510(k) clearance on 2018-05-04, under approval number K180313.

What company makes Apollo TMS Therapy System?

Apollo TMS Therapy System is manufactured by Mag & More GmbH.

What is the FDA product code for Apollo TMS Therapy System?

The FDA product code for Apollo TMS Therapy System is OBP.

Related Clinical Trials

Related PubMed Literature

Other Devices by Mag & More GmbH

Related Devices (Code: OBP)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.